Vestmark Advisory Solutions’s Alexion Pharmaceuticals ALXN Stock Holding History

Vestmark Advisory Solutions’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,142	Closed	-$1.12M	–	759
2020 Q4	$1.12M	Buy	7,142 +405	+6%	+$52K	0.13%	223
2020 Q3	$771K	Buy	6,737 +624	+10%	+$67.3K	0.1%	256
2020 Q2	$686K	Buy	6,113 +733	+14%	+$77.8K	0.11%	250
2020 Q1	$483K	Buy	+5,380	New	+$528K	0.09%	275
2019 Q4	–	Sell	-5,424	Closed	-$531K	–	544
2019 Q3	$531K	Buy	5,424 +2,018	+59%	+$227K	0.09%	288
2019 Q2	$446K	Buy	3,406 +164	+5%	+$21.1K	0.08%	305
2019 Q1	$438K	Buy	+3,242	New	+$403K	0.08%	307

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vestmark Advisory Solutions's ALXN Position: Q1 2021 in Review

Vestmark Advisory Solutions sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 7,142 shares — an estimated $1.12M sold.

Vestmark Advisory Solutions first reported a position in ALXN in Q1 2019 and held it in 7 quarters. The position peaked at $1.12M in Q4 2020. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

Vestmark Advisory Solutions reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Vestmark Advisory Solutions sold 7,142 Alexion Pharmaceuticals shares in Q1 2021, an estimated $1.12M.
Vestmark Advisory Solutions first reported a position in Alexion Pharmaceuticals in Q1 2019 and held it in 7 quarters.
Vestmark Advisory Solutions's Alexion Pharmaceuticals position peaked at $1.12M in Q4 2020.
754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Vestmark Advisory Solutions's 13F filing for Q1 2021, filed 10 May 2021.